The eects of Fibroblast Growth Factor-2 (FGF-2) on breast cancer cell DNA synthesis are controversial. To elucidate the mechanisms by which FGF-2 stimulates or inhibits DNA synthesis, we analysed FGF-2 signaling pathways in breast cancer MCF-7 and MCF-7 cells overexpressing Ha-Ras (MCF-7ras). We found that FGF-2-induction of DNA synthesis correlates with Ras transient activation, FRS-2 tyrosine phosphorylation and low level of expression of p66 Shc . In addition, Nckassociated proteins are highly tyrosine phosphorylated and JNK reaches a higher level of activation when FGF-2 triggers DNA synthesis. Interestingly upon FGF-2 treatment, JNK activation and DNA synthesis are dependent on Rac-1 activity. These results con®rm that in MCF-7 cells, induction of DNA synthesis by FGF-2 requires a transient activation of the Ras/MAPK cascade and demonstrates for the ®rst time that intact Rac-1 and Nck signaling networks are required.
Introduction
Fibroblast growth factor 2 (FGF-2) belongs to a family of heparin-binding polypeptides including 18 members which share 30 ± 60% amino acid identity (Ohbayashi et al., 1998; Jaye et al., 1986; Bikfalvi et al., 1997; Miyamoto et al., 1993; Yamasaki et al., 1996) . Cell response to FGF-2 is mediated by a dual receptor system consisting of low and high anity binding sites (Yayon et al., 1991) . The latter belongs to the FGF tyrosine kinase receptor (RTK) family, which consists of four distinct members named FGFR-1 through FGFR-4 (Kavanaugh and Williams, 1994; Vainikka et al., 1994) . FGF-2 binding to these RTKs enhances their intrinsic tyrosine kinase activity (Mohammadi et al., 1996a) and creates docking sites for SH2 or PTB domain-containing proteins (Blaikie et al., 1994; Kavanaugh and Williams, 1994) . Among these proteins, PLCg, Shc and a new family of proteins named Suc-1 associated neurotrophic factor target-like proteins (SLP) have been shown to bind FGFRs and/ or to be tyrosine phosphorylated upon FGF-2 stimulation (Mohammadi et al., 1996b; Vainnikka et al., 1994; Kanai et al., 1997; Klint et al., 1995; Ong et al., 1996; Wang et al., 1996) . Tyrosine phosphorylation of Shc and SLP, by their interaction with Grb-2, were reported to mediate FGF-induced Ras activation (Mohammadi et al., 1996a,b; Ong et al., 1996; Wang et al., 1996) , resulting in the activation of Ras-dependent signaling pathways such as the MAP kinase cascade (Mohammadi et al., 1996b) . Recently, Kouhara et al. (1997) discovered a novel phosphoprotein associated with and phosphorylated by FGFRs. This protein of 92 ± 95 kDa, named FRS-2, belongs to the SLP family and functions as a lipid-anchored docking protein essential for FGF induced proliferation and/or dierentiation.
FGF-2 is detected in the myoepithelial cells of normal breast tissue (Gomm et al., 1991) and at lower levels in malignant breast tissue as determined by immunochemistry, Western blotting and RT ± PCR experiments (Yiangou et al., 1997) . Since breast cancer cells express FGFRs and respond to FGF-2, it was of great interest to examine how this growth factor may aect mitogenesis and analyse the implicated intracellular signaling pathways. FGF-2 stimulates DNA synthesis in some breast cancer cell lines such as MCF-7 (Karey and Sirbasku, 1988) , and interestingly, inhibits it in MDA-MB-134 breast cancer cells (McLeskey et al., 1994) . Recently, we and others have shown that a sustained activation of the MAPK pathway is correlated with an arrest of the cell cycle (Liu et al., 1998; Kerkho et al., 1998) and this eect could be mediated by the MAPK-dependent expression of the CDC inhibitor p21 WAF/CIP1 Fenig et al., 1997) . Moreover, the cell cycle arrest via p21 WAF/CIP1 has been reported to be dependent on Ras activation and counterbalanced by overexpression of Rho (Olson et al., 1998) . Therefore to understand how FGF-2 stimulates or inhibits DNA synthesis in MCF-7 cell, we investigated signaling pathways initiated by FGF-2 in MCF-7 cells and in a derived clone constitutively expressing Ha-Ras (MCF-7ras).
We show that inhibition of DNA synthesis in MCF7ras cells upon FGF-2 treatment correlates with an increase in expression of p66 Shc , a modi®cation of total protein tyrosine phosphorylation, an alteration of the JNK and MAPK pathways, and ®nally with dierent cytoskeletal rearrangements. Moreover we demonstrate that Rac-1 and Nck signaling networks are necessary for FGF-2-induced DNA synthesis in MCF-7 cells. We propose a model involving Raf-dependent and independent pathways in the control of cell proliferation induced by FGF-2.
Results
Eect of FGF-2 on DNA synthesis in MCF-7 and MCF-7ras cells FGF-2 is known to be a mitogenic factor for serumdeprived MCF-7 cells (Karey and Sirbasku, 1988; Stewart et al., 1992) . However, FGF-2, through its binding to FGFRs and activation of MAP kinase, inhibits growth of proliferating MCF-7 or MDA-MB-134 cells McLeskey et al., 1994) . To further characterize FGF-2-mediated mitogenesis in MCF-7 cells, we compared the eect of FGF-2 on DNA synthesis in MCF-7 and MCF-7 cells overexpressing Ras, either in the absence or in the presence of insulin. In the absence of insulin, FGF-2 stimulated [ 3 H]thymidine incorporation in MCF-7 cells (Figure 1 ). The maximal increase (twofold) was observed at 0.1 ng/ml of FGF-2. In MCF-7ras cells, FGF-2 in the presence or in the absence of insulin, did not stimulate [ 3 H]thymidine incorporation and at concentrations higher than 0.1 ng/ml, inhibited basal DNA synthesis ( Figure 1) . A similar eect of FGF-2 was observed in MCF-7 cells incubated in the presence of insulin. These opposite eects of FGF-2 on DNA synthesis in MCF-7 and MCF-7ras cells were abolished by co-incubating the cells with 10 mg/ml of anti-FGF-2 antibodies (data not shown), demonstrating the speci®city of the FGF-2 eects. Moreover, these dierent responses cannot be attributed to dierences in FGFR expression, since both cell lines expressed the same amount of high and low anity FGF-2 binding sites (data not shown).
Correlation of Ras activity and FGF-2-induced DNA synthesis
In response to FGF-2, [ 3 H]thymidine incorporation in MCF-7 and MCF-7ras cells revealed that overexpression of Ha-Ras abolished the stimulatory eect of FGF-2. To further understand this observation, we evaluated Ras expression and activity in both cell lines. As expected, quanti®cation of Ras by Western blotting con®rmed that the Ras protein level was 3.5 ± 4-fold higher in MCF-7ras than in MCF-7 cells (Figure 2a) . We next measured Ras-GTP loading activity upon FGF-2 stimulation in both cell types in the absence or presence of 10 mg/ml of insulin (Figure 2b) . In untreated cells, Ras-GTP represented 4% of total cellular Ras in MCF-7 cells and 13% in MCF-7ras cells, re¯ecting the higher level of Ras in this cell line. In the absence of insulin, GTP bound to p21
Ras was found to increase to 42% after 5 min of FGF-2 treatment in MCF-7 cells and to 63% in MCF-7ras cells. Furthermore, after 60 min of FGF-2 treatment, the Ras-GTP level decreased to 20% in MCF-7 cells while 55% of p21
Ras were still loaded with GTP in MCF-7ras cells (Figure 2b ). In the presence of insulin, FGF-2 treatment showed the same pro®le for Ras-GTP loading in MCF-7 and MCF-7ras cells. Overall, the kinetics of loading and GDP/GTP exchange in MCF-7 cells in the presence of insulin was comparable to that for MCF-7ras cells as shown in Figure 2b . These results show a correlation between sustained high level of Ras activity and inhibition of DNA synthesis.
Increased expression of p66
Shc and lack of FRS-2 tyrosine phosphorylation in MCF-7ras cells
To de®ne how a sustained high level of Ras activity abolishes DNA synthesis in response to FGF-2, we analysed speci®c signaling molecules involved in Ras activation downstream of FGFRs. Presently, only two such molecules have been identi®ed, one of them being the adaptor protein Shc (Mohammadi et al., 1996b) . Using lysates of FGF-2-stimulated MCF-7 and MCF7ras cells, Shc proteins (p46, p52 and p66) were immunoprecipitated and analysed for tyrosine phosphorylation by Western blotting using an anti-PY antibody ( Figure 3a , upper panel). In both cell-lines, a 52 kDa tyrosine phosphorylated band appeared after 5 Shc , its tyrosine phosphorylation in response to FGF-2 was enhanced in MCF-7ras compared to MCF-7 cells. In addition, p46 and p66
Shc were tyrosine phosphorylated only in MCF7ras cells treated with FGF-2 for 5 min. In both cell lines p46
Shc was expressed to the same extent but surprisingly p66
Shc was detected only in MCF-7ras cells ( Figure 3a , bottom panel). Interestingly, in FGF-2-stimulated MCF-7 cells, two other tyrosine phosphorylated proteins (pp35, pp37) which co-immunoprecipitated with Shc, were not detected in MCF-7ras cells. These proteins were identi®ed as LAT-related proteins based on their immunoreactivity with speci®c anti-LAT antibodies (data not shown). These results suggest that Shc proteins were preferentially tyrosine phosphorylated in MCF-7ras cells under FGF-2 stimulation and also that speci®c interaction of Shc with additional tyrosine phosphorylated proteins no longer prevailed in this cell line. Furthermore, the presence of p66 The second molecule involved in mediating Ras activation by FGFRs is SNT (Rabin et al., 1993) , named also SLP (Wang et al., 1996) or more recently FRS-2 (Kouhara et al., 1997) . As shown in Figure 3b (upper panel), FRS-2 tyrosine phosphorylation increased twofold after 5 min and sixfold after 60 min of FGF-2 stimulation in MCF-7 cells. In contrast, no FRS-2 tyrosine phosphorylation was observed in MCF-7ras cells although similar levels of FRS-2 were detected as compared to MCF-7 cells (Figure 3b , lower panel).
Raf-1 and MAPK pathways are dierently regulated by FGF-2 in MCF-7 and MCF-7ras cells
We investigated the activation of Ras-dependent signaling molecules in response to FGF-2 in MCF-7 and MCF-7ras cells. Raf-1 kinase activity was stimulated in MCF-7 cells to the same extent (fourfold) after 5 and 60 min of FGF-2 treatment ( Figure 4a ). In contrast, in MCF-7ras cells, Raf-1 was already activated with a basal activity 9.4-fold higher than in MCF-7 cells. Interestingly, in MCF-7ras cells, 5 min of FGF-2 treatment inhibited Raf-1 activity to a RasGAP was already found co-immunoprecipitating with Nck. After 5 min of FGF-2 treatment, the amount of associated p120
RasGAP increased in these cell lines. In contrast, in untreated MCF-7ras cells, p120
RasGAP was not found complexed with Nck, but FGF-2 strongly stimulated the formation of the Nck-p120
RasGAP complex ( Figure  5 ). After 5 min of FGF-2 treatment, tyrosine phosphorylation of p120
RasGAP detected in Nck immuno-complexes was lower in MCF-7ras than in MCF-7 cells in spite of a similar amount of p120
RasGAP co-immunoprecipitated with Nck in both cell lines. This suggests that the FGF-2-dependent association of p120
RasGAP with Nck could be independent of tyrosine phosphorylation and mediated by a third protein still to be identi®ed. The tyrosine phosphorylated p35±37 proteins were detected in Nck immunoprecipitates only in MCF-7 cells. These proteins were identi®ed as LAT-related (LAT-R) proteins (Zhang et al., 1998) Rac-1 activity is required for FGF-2-induced DNA synthesis Polymerization of actin ®bers was studied by phalloidin TRITC staining in FGF-2 stimulated MCF-7 and MCF-7ras cells. In both cell types, FGF-2 induced actin polymerization at the leading edge of the cellular plasma membrane, provoking extension of lamellipodia and subsequent membrane rues. Seventy to 80% of the cells showed this phenotype (Figure 7) . However, in MCF-7ras cells (Figure 7c,d) , the staining of actin-containing ®lopodial protrusions observed at the cell periphery was lower than in MCF-7 cells (Figure 7a,b) , indicating dierences in activation of the Rho family members Rac and Cdc42 by FGF-2. In order to investigate alterations in the downstream targets of the Rho family of GTPases, we measured JNK activity by in vitro phosphorylation of the GSTjun fusion protein. As shown in Figure 8a ,b, JNK-1 basal activity was similar in MCF-7 and MCF-7ras cells. After 5 min of FGF-2 stimulation, JNK-1 activity was stimulated in both cell lines. While after 60 min of FGF-2 treatment, JNK-1 activity continued to increase in MCF-7 cells it showed a slight decrease in MCF-7ras cells (Figure 8b) . In MCF-7 cells transiently transfected with a dominant negative Rac-1 (N17Rac), as expected, JNK activity induced by FGF-2 was dramatically reduced after 60 min of treatment (Figure 9a ). However, in these cells MAPK activation by FGF-2 was normal (Figure 9b) . Interestingly, when DNA synthesis triggered by FGF-2 was evaluated, N17Rac expressing cells did not respond to FGF-2. These results suggest that Rac-1 is involved in DNA synthesis induced by FGF-2 in MCF-7 cells. 1988; Stewart et al., 1992) . However, in proliferating MCF-7 cells, FGF-2 inhibition of DNA synthesis correlated with a sustained MAPK activation . In previous studies, we and others have demonstrated that the duration of the MAPK activation determines the eect of FGF-2 on cell proliferation (Liu et al., 1998; Albas et al., 1998) . Moreover speci®c signaling molecules such as Shc, were involved in cell proliferation through regulation of the MAPK pathway (Migliaccio et al., 1997; Kouhara et al., 1997) . Interestingly, we show here that p66
Discussion

FGF-2 was reported to be mitogenic for MCF-7 cells under serum-depletion conditions (Karey and Sirbasku,
Shc is overexpressed in MCF-7ras cells and tyrosine phosphorylated upon FGF-2 treatment. Recently, the expression of p66
Shc was reported to inhibit cell proliferation in response to growth factors (Migliaccio et al., 1997) by preventing MAPK activation (Okada et al., 1997) . Thus, in MCF-7ras cells, overexpression of p66 Shc may in part be responsible for the inhibitory eect of FGF-2 on DNA synthesis without preventing FGF-2-induced MAPK activation as described for EGF (Okada et al., 1997) .
Likewise, tyrosine phosphorylation of FRS-2, which is important for protein scaolding (Kouhara et al., 1997) , is detected in MCF-7 cells in response to FGF-2 but not in MCF-7ras. Ong et al. (1997) have described the presence of FRS-2 in a FGF-2-induced complex containing Gab-1 and the tyrosine phosphatase SHP2. Moreover, a FRS-2 de®cient in both Grb2 and SHP2 binding, induces only a weak and transient MAPK activation (Haradi et al., 1998) . Together, these results suggest that the lack of FRS-2 tyrosine phosphorylation in response to FGF-2 as well as overexpression of p66 Shc may participate in the inhibition of DNA synthesis observed in MCF-7ras cells.
In this study, we found that upon FGF-2 treatment, Nck is complexed with p120 RasGAP . Interestingly, p120
RasGAP is only tyrosine phosphorylated in MCF-7 cells. This suggests two mechanisms for p120
RasGAP Nck association. In MCF-7 cells, the association requires p120
RasGAP tyrosine phosphorylation while in MCF-7ras cells, the association is Nck tyrosine phosphorylationdependent. A similar mechanism mediating the interaction of p120
RasGAP and p190 RhoGAP has also been recently described (Roof et al., 1998) .
Nck is required for PDGF-induced DNA synthesis in ®broblasts (Roche et al., 1996) , and its overexpression in PC12 cells inhibits FGF-2-induced dierentiation in a MAPK independent manner (Rockow et al., 1996) . Therefore, in MCF-7 cells, the signaling pathway involving Nck in FGF-2-induced DNA synthesis requires a dierent mechanism other than the classical MAPK pathway. Surprisingly, in MCF-7 and MCF-7ras cells, we have shown the presence of a constitutive association of Nck with LAT related molecules. LAT expression has been reported in the immune system (Zhang et al., 1998) and has been shown to mediate signaling through the MAPK pathway, PLCg or Rho family GTPases (Cantrell, 1998) . Recently, Nck was reported to couple Figure 10 Schematic representation of the transduction pathways involved in FGF-2 mediated mitogenesis in MCF-7 or MCF-7ras cells. The cytoplasmic (Cyt) events occurring after FGF-2 stimulation trigger nuclear (Nuc) regulation of DNA synthesis. The activity of ERK/MAPK or JNK/SAPK is signi®ed by a (+) symbol when positively regulated, and by a (7) symbol when negatively regulated. FGF-2 induces cytoplasmic phosphorylation (P) of several proteins and protein-protein interactions. Dashed lines indicate a non-demonstrated pathway or interaction activation of EphB1 receptor to JNK stimulation (Stein et al., 1997) . In MCF-7 cells, JNK activity was strongly stimulated after 60 min of FGF-2 treatment without direct association of Nck with the FGFR. Therefore, we suggest that in MCF-7 cells, constitutive Nck association with the LAT-R proteins mediates signaling from the FGFR to JNK through a Rac-1 dependent pathway. The requirement of Rac-1 for JNK activation and DNA synthesis in MCF-7 cells might be comparable to the requirement of an active Rho to suppress Ras induction of p21 WAF/CIP1 resulting in DNA synthesis (Olson et al., 1998) .
Finally, as summarized in Figure 10 , these results suggest a model in which signaling networks involving Rac-1 and Nck play a critical role in stimulation of DNA synthesis by FGF-2 in MCF-7 cells.
Materials and methods
Antibodies
Nck, p120
RasGAP , JNK-1, ERK-1/2, Raf-1, FRS-2, FGFR-1 and FGFR-2 antibodies were purchased from Santa Cruz Biotechnologies (Sant Cruz, CA, USA). Anti-LAT antibody was from UBI (Lake Placid, NY, USA), anti Shc-SH 2 domain antibody was prepared as previously described (Di Guglielmo et al., 1994) , PY-20 antibody was from Sigma (St Louis, MI, USA). The p13 suc-1 -agarose beads were from Calbiochem (San Diego, CA, USA). GST-MEK-1 and GST-ERK-1 were a gift from Dr A Nantel (Montreal, Canada). N17Rac was constructed as previously described (Qiu et al., 1995) and introduced into pcDNA3 vector.
Cell culture
MCF-7 (HBT22) cells derived from pleural metastases of a ductal human breast carcinoma were obtained from the American Type Culture Collection (Rockville, MD, USA). The MCF-7ras cell line, established by transfection of v-HaRas cDNA in MCF-7 cells (Sommers et al., 1990; Gelmann et al., 1992) , was a gift from Dr C Sommers. Cells were grown in DMEM containing 10% heat-inactivated fetal bovine serum (FBS) and 2 mM L-Glutamine in the presence or not of 10 IU/ml insulin at 378C in a 7% CO 2 -humidi®ed atmosphere.
[
H]thymidine incorporation assay
Cells were seeded onto a 48-well plates (4610 4 cells/well) and were grown in DMEM containing 10% FBS for 24 h in the presence or absence of insulin. The cells were starved for 24 h in serum free medium then treated with 0.01 ± 10 ng/ml of FGF-2 in serum free medium+insulin for a further 24 h and 0.5 mCi of [ 
Ras-GTP loading assay
MCF-7 and MCF-7ras cells (10 5 ) were grown in DMEM containing 0.5% FBS for 16 h and 3 h in phosphate-free DMEM prior to labeling with 100 mCi/ml of 32 P-orthophosphate (3000 Ci/mmol) for 3 h. After stimulation for 5 and 60 min with 10 ng/ml FGF-2, cells were lysed as described by Medema et al. (1993) , and Ras was immunoprecipitated with the monoclonal antibody Y13-259. Alternatively Shc was immunoprecipitated as a control. After extensive washing of the immunoprecipitates, bound nucleotides were eluted and separated by TLC as described by Medema et al. (1993) . Spots corresponding to GTP and GDP were excised and radioactivity determined by scintillation counting.
Immunoprecipitation and immunoblotting
Cells (1 ± 3610 7 ) were lysed in 1 ml of 20 mM Tris-HCl pH 7.6, 150 mM NaCl, 10% glycerol, 1 mM NaVO 4 , 1 mM PMSF, 1 mg/ml leupeptin and 1% Nonidet P-40 (extraction buer or EB). Cellular extracts (CE) were clari®ed by centrifugation for 15 min at 15 000 g. Proteins (corresponding to 10 6 cells) were: (i) directly separated on SDS ± PAGE; or (ii) precleared with protein-A-Sepharose and immunoprecipitated with the previously described antibodies overnight at 48C followed by the addition of Protein-A-Sepharose for 2 h with rotation at 48C; or (iii) incubated with p13 suc-1 conjugated to agarose beads (Calbiochem, San Diego, CA, USA) for 2 h at 48C. Following precipitation, the beads were washed three times with EB and once with PBS. Finally, the beads were resuspended in 50 ml of Laemmli sample buer (Laemmli, 1970) , boiled 5 min and eluted proteins separated by SDS ± PAGE. Proteins were electrotransferred onto Immobilon P or nitrocellulose membranes according to the manufacturer's recommendations, after which the membranes were washed twice in PBS containing 0.1% Tween 20 (PBST), blocked in PBST plus 3% BSA and then incubated overnight at 48C in PBST containing 0.1% BSA and the indicated antibodies. Horse radish peroxidase conjugated or 125 I anti-rabbit or anti-mouse IgG antibodies were utilized to visualize immuno-reactive bands.
Raf Kinase assay
Raf-1 proteins were immunoprecipitated for 2 h at 48C from 500 mg of cell extract as described above. The beads were washed once with 30 mM Tris-HCl, 0.2 mM EDTA, 0.3% (v/ v) b-mercaptoethanol, 10% glycerol, 0.1% Triton X-100, 5 mM NaF, 0.2 mM Na 3 VO 4 , pH 7.5 containing 1 M KCl and once with the same buer without KCl. The beads were then resuspended in reactivation buer (Marais et al., 1995) in the presence of 10 mg/ml GST-MEK-1 and 100 mg/ml GST-ERK-1. The beads were then incubated at 308C for 20 min and the reaction terminated by the addition of one volume of reactivation buer without MgCl 2 and ATP but with 20 mM EDTA. The supernatant was collected and the GST-ERK-1 activity contained in 20 ml was assayed by phosphorylation of MBP as described below.
JNK and ERK assays
Immunoprecipitation were performed as described above with anti ERK-1/2 and anti JNK-1 antibodies, and after two EB washes, Protein A-Sepharose beads were washed three times in 20 mM HEPES pH 7.6, 10 mM b-glycerophosphate, 10 mM MgCl 2 , 50 mM NaVO 4 and 10 mM DTT (Kinase Buer, KB). The assay was then carried out for 30 min at 308C in 30 ml of KB containing 50 mM ATP, 0.5 mCi [g-32 P]ATP (ICN, Costa Mesa, CA, USA) and 5 mg of Myelin Basic Protein (Life Technologies, Gaithesburg, MD, USA) for the ERK activity or GST-jun fusion protein for the JNK-1 activity (Rodrigues et al., 1997) . Supernatants were then collected and the reaction stopped by adding 30 ml of 26Laemmli sample buer. Radiolabeled proteins were separated by 12% SDS ± PAGE and analysed by autoradiography on X-OMAT AR ®lms.
Identi®cation of LAT related proteins/mRNAs in MCF-7 cells
LAT was ®rst identi®ed in MCF-7 and MCF-7ras cell lysates by immunoblotting. Trizol puri®ed total RNAs (5 mg) were converted to single-stranded cDNA (SuperScript II Kit, Life Technologies) with an oligo (dT)12 ± 18 primer (25 mg/ml). The PCR reactions were performed according to the manufacturer's instruction for 35 cycles (948C, 30 s; 558C, 60 s; 728C, 60 s), using the primers 5'-ATGGAGGAGGC-CATC-3'(1) and 5'-TCAGTTCAGCTCCTG-3'(2), 5'-GCGT-CTGGGATCCGAGGTG-3'(3), 5'-CACCTCGGATCCCA-GACGC-3'(4) as described in Figure 5a . The ampli®ed products were electrophoresed on 1% agarose gels, blotted onto nylon membranes, and hybridized using a 32 P-ATPlabeled EcoRI/PstI cDNA fragment of the human LAT encoding EST64361 clone.
Membrane ruing assay
Cells were grown on glass coverslips to semi-con¯uency and starved in serum-free medium overnight. Cells were then stimulated by the addition of 50 ng/ml of FGF-2 in the presence or absence of insulin in serum-free medium for 10 min. After a brief wash with PBS, cells were ®xed in 3% formaldehyde in PBS for 10 min, permeabilized with 0.2% Triton X-100 in PBS for 5 min and treated with 50 mM NH 4 Cl in PBS for 10 min. Polymerized actin ®laments were visualized using a¯uorescence microscope, by incubation of the ®xed cells with phalloidin-tetramethyl-rhodamine isothiocyanate (TRITC) for 1 h, followed by extensive PBS washing.
